BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31543462)

  • 41. A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron-refractory iron deficiency anemia.
    Choi HS; Yang HR; Song SH; Seo JY; Lee KO; Kim HJ
    Pediatr Blood Cancer; 2012 Apr; 58(4):640-2. PubMed ID: 21618415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver HFE protein content is posttranscriptionally decreased in iron-deficient mice and rats.
    Frýdlová J; Rogalsky DW; Truksa J; Traeger L; Steinbicker AU; Vokurka M; Krijt J
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G560-G568. PubMed ID: 29927322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage.
    Enns CA; Ahmed R; Zhang AS
    J Biol Chem; 2012 Oct; 287(42):35104-35117. PubMed ID: 22893705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac
    Bigorra Mir M; Charlebois E; Tsyplenkova S; Fillebeen C; Pantopoulos K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein.
    Zhang AS; Anderson SA; Wang J; Yang F; DeMaster K; Ahmed R; Nizzi CP; Eisenstein RS; Tsukamoto H; Enns CA
    Blood; 2011 Feb; 117(5):1687-99. PubMed ID: 21115976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
    Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
    Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2.
    Häußler D; Mangold M; Furtmann N; Braune A; Blaut M; Bajorath J; Stirnberg M; Gütschow M
    Chemistry; 2016 Jun; 22(25):8525-35. PubMed ID: 27214780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.
    Lin L; Goldberg YP; Ganz T
    Blood; 2005 Oct; 106(8):2884-9. PubMed ID: 15998830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron-refractory iron deficiency anemia.
    Finberg KE
    Semin Hematol; 2009 Oct; 46(4):378-86. PubMed ID: 19786206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased hemojuvelin protein levels in mask mice lacking matriptase-2-dependent proteolytic activity.
    Frýdlová J; Fujikura Y; Vokurka M; Nečas E; Krijt J
    Physiol Res; 2013; 62(4):405-11. PubMed ID: 23590607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids.
    St-Georges C; Désilets A; Béliveau F; Ghinet M; Dion SP; Colombo É; Boudreault PL; Najmanovich RJ; Leduc R; Marsault É
    Eur J Med Chem; 2017 Mar; 129():110-123. PubMed ID: 28219045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
    Schmidt PJ; Liu K; Visner G; Fitzgerald K; Fishman S; Racie T; Hettinger JL; Butler JS; Fleming MD
    Am J Hematol; 2018 Jun; 93(6):745-750. PubMed ID: 29498084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HFE mRNA expression is responsive to intracellular and extracellular iron loading: short communication.
    Mehta KJ; Farnaud S; Patel VB
    Mol Biol Rep; 2017 Oct; 44(5):399-403. PubMed ID: 28840425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.
    Wallace DF; Secondes ES; Rishi G; Ostini L; McDonald CJ; Lane SW; Vu T; Hooper JD; Velasco G; Ramsay AJ; Lopez-Otin C; Subramaniam VN
    Br J Haematol; 2015 Mar; 168(6):891-901. PubMed ID: 25403101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication.
    Mehta KJ; Busbridge M; Patel VB; Farnaud SJ
    Mol Cell Biochem; 2020 May; 468(1-2):121-128. PubMed ID: 32185675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2.
    Duchêne D; Colombo E; Désilets A; Boudreault PL; Leduc R; Marsault E; Najmanovich R
    J Med Chem; 2014 Dec; 57(23):10198-204. PubMed ID: 25387268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: identification of a hypoxia-responsive element in the TMPRSS6 promoter region.
    Maurer E; Gütschow M; Stirnberg M
    Biol Chem; 2012 May; 393(6):535-40. PubMed ID: 22628316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Progress in iron metabolism research].
    Kawabata H
    Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.